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SUMMARY – The aim of this study was to determine arterial stiffness and the effect of stenting 
in patients with renal artery stenosis. We hypothesized that ostial renal artery stenosis is not only a 
marker of more pronounced atherosclerosis of large arteries, but is also a predictor of higher cardio-
vascular mortality. We enrolled 33 patients with renal artery stenosis refractory to pharmacological 
treatment and divided them according to the renal artery stenosis location, ostial and truncal (23 vs. 
10 patients). We analyzed patient survival at five-year follow up. After the intervention and at six-
month follow up, there was a significant decrease in blood pressure values, as well as in pulse wave 
velocity (PWV) and augmentation index. PWV was significantly lower in patients with truncal renal 
artery stenosis and these patients were significantly younger. Twelve patients with ostial and one pa-
tient with truncal renal artery stenosis (52% vs. 10%, p<0.001) died from cardiovascular events. Our 
study is the first to confirm the predictive role of PWV and arterial stiffness in patients with renal ar-
tery stenosis, especially ostial one, and to emphasize its ability of detecting future higher incidence of 
cardiovascular events.
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Introduction
The incidence of renal artery stenosis is high in pa-
tients with advanced atherosclerosis. Patients with pe-
ripheral arterial disease, coronary arterial disease, un-
controlled arterial hypertension or renal insufficiency 
have an increased risk of renal artery stenosis1-3. Myo-
cardial infarction, stroke, peripheral arterial disease 
and cardiovascular death are strongly correlated with 
renal artery stenosis, which is an independent predic-
tor of these events4-6. The severity of renal artery steno-
sis is strongly correlated with higher mortality, espe-
cially in patients with bilateral renal artery stenosis7, or 
in patients with accompanying coronary arterial dis-
ease. Arterial stiffness is a marker of atherosclerosis 
and is associated with hypertension, especially when 
untreated8,9. The predictive value of arterial stiffness, 
which is a marker of target organ damage, is well es-
tablished for cardiovascular events and morbidity8-10, 
but data on arterial stiffness in patients with renal ar-
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tery stenosis are rather scarce11. Renal artery stenosis is 
a marker of advanced atherosclerosis12, as well as arte-
rial stiffness, with associated implications for future 
cardiovascular events and patient mortality. Recent tri-
als failed to prove the advantages of stenting compared 
to intensive medical therapy13, but endovascular inter-
vention should be considered in patients with signifi-
cant stenosis and severe symptoms14,15. Renal artery 
stenosis is often seen in older patients with aortoscle-
rosis and is often located in the ostium with extension 
to the aorta. Treatment of ostial renal artery stenosis is 
associated with higher restenosis rates and lower pro-
cedural success16. Regarding the different anatomic 
locations of renal artery stenosis and possible correla-
tion of ostial stenosis with atherosclerosis of large ar-
teries compared to truncal stenosis17, we hypothesized 
that ostial renal artery stenosis is a marker of more 
pronounced atherosclerosis of large arteries. Therefore, 
the aim of this study was to determine arterial stiffness 
in patients with functional grade III renal artery ste-
nosis which is defined as stenosis with resistant hyper-
tension, abnormal renal function or volume overload14, 




In this retrospective longitudinal study, we enrolled 
33 patients with atherosclerotic renal artery stenosis 
that was refractory to pharmacological treatment. 
These patients were divided into two subgroups ac-
cording to the renal artery stenosis location, ostial and 
truncal (23 vs. 10 patients). Both subgroups of patients 
were referred to our outpatient clinic between Febru-
ary 2009 and August 2011.
The inclusion criteria were patients older than 18 
years, uncontrolled hypertension (office blood pressure 
(BP) ≥140/90 mm Hg despite using more than two 
antihypertensives), kidney length ≥7 cm, chronic kid-
ney disease (CKD) stages ≥4, and renal artery stenosis 
≥60% confirmed by digital subtraction angiography 
(DSA) and based on visual estimation. The exclusion 
criteria were intrarenal artery resistance index ≥0.80, 
bilateral stenosis of renal arteries, fibromuscular dys-
plasia, occlusion or dissection of renal artery, pregnan-
cy, or a history of stroke, acute heart failure, pulmonary 
edema, or myocardial infarction within six months of 
the study initiation. A written informed consent was 
obtained from each participant and the study protocol 
was approved by the local Ethics Committee. Each 
patient underwent complete clinical and laboratory 
workup at admission and at six-month follow up. 
 Renal function was defined as estimated creatinine 
clearance (estimated glomerular filtration rate, eGFR, 
mL/min), which was estimated using the simplified 
Modification of Diet in Renal Disease equation.
Arterial blood pressure, pulse wave velocity  
and augmentation index measurements
Office brachial BP and heart rate were measured 
using the M6 Comfort device Intellisense (Omron, 
Kyoto, Japan) 24 h and 48 h before stenting, and six 
months after the intervention. The mean value of three 
measurements was used on further analysis. The Arte-
riograph device (TensioMed Ltd., Budapest, Hunga-
ry) was used to determine the indices of arterial stiff-
ness, i.e. pulse wave velocity (PWV), augmentation 
index (AIx) and central systolic BP, both before revas-
cularization and at six-month follow up. We analyzed 
patient survival at five-year follow up.
Diagnostic and endovascular procedure
All study patients underwent baseline kidney ultra-
sound and color Doppler ultrasound examination. Lo-
calization, extension and severity of renal artery steno-
sis was determined by multidetector computed tomog-
raphy (MDCT) or magnetic resonance (MR) angiog-
raphy, and later confirmed by DSA. Initial laboratory 
workup and measurements were performed on the day 
before the endovascular intervention and patients re-
ceived 325 mg of aspirin and 300 mg of clopidogrel 
thereafter. After the endovascular intervention, patients 
were administered 100 mg aspirin for life and 75 mg of 
clopidogrel for three months. All invasive diagnostic 
and interventional procedures were performed using a 
non-ionic iodine contrast agent and conducted in local 
anesthesia, conscious sedation and analgesia. The ac-
cess site was either femoral or brachial artery. All pro-
cedures were performed through the 7F RDC or HS 
introducer guide catheter (Vista BriteTip IG, Cordis, 
USA) for femoral access and 6F Special guiding cath-
eter (Vista BriteTip, Cordis, USA) for transbrachial 
access. Stenotic segment of renal artery was crossed with 
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0.014’’ guidewire and a cobalt chromium balloon-ex-
pandable stent was implanted. A bolus of 5000 IU hep-
arin was administered intra-arterially at the beginning of 
the intervention. There were no angiographic complica-
tions or contrast-induced nephropathy observed. All 
measurements and laboratory workup were repeated at 
six-month follow up.
Statistical analysis
Statistical analysis was performed using SPSS ver-
sion 20 (IBM, Endicott, NY, USA). The normality of 
data distribution was tested using Kolmogorov-Smirnov 
test. Preliminary analyses were performed to ensure no 
violation of the assumptions of normality, linearity and 
homoscedasticity. Normally distributed variables were 
compared using Student’s t-tests for unpaired and 
paired samples, whereas non-normally distributed vari-
ables were compared using Mann-Whitney U (un-
paired) and Wilcoxon (paired) tests. Baseline-to-follow 
up comparisons were done using Student’s t-test for 
paired samples and Wilcoxon test. Categorical variables 
were compared with χ2-tests. ANCOVA was used to 
compare adjusted means over several groups. Correla-
tions were performed using Pearson correlations for 
normally distributed and Spearman rho for non-nor-
mally distributed variables. Multiple linear regression 
was used to explore the influence of different variables 
on survival. A two-tailed test p-value <0.05 was consid-
ered statistically significant.
Results
Demographic and clinical characteristics of en-
rolled patients (mean age 64.3±10.3; men 15/48.4%) 
are shown in Table 1. Hypercholesterolemia was pres-
ent in 29 (93.5%) patients, 13 (41.9%) patients were 
smokers, and eight (25.8%) patients had diabetes. 
The mean percentage of renal artery stenosis was 
82.5±10.7% and the mean stenosis length was 11.5±3.9 
mm. Left and right renal arteries were equally affected 
(17/16). Stenosis was determined by measuring the ra-
tio between diameter of the narrowest segment of the 
imaged renal artery and diameter of a normal segment 
of the artery proximal to the stenosis or distal to post-
stenotic dilatation. At baseline, all patients with renal 
artery stenosis received a mean of 4.1 antihypertensive 
drugs and 2.9 antihypertensive drugs at six-month fol-
low up. The distribution of drugs was as follows: angio-
Table 1. Demographic, clinical and hemodynamic 




Body mass index (kg/m2) 27.4±3.0
Sex (male) 15 (48.4%)
Hypercholesterolemia (yes) 29 (93.5%)
Smokers (yes) 13 (41.9%)
Ischemic heart disease (yes) 11 (35.5%)
Cerebrovascular disease (yes) 4 (12.9%)
Peripheral arterial disease (yes) 15 (48.4%)
Diabetes (yes) 8 (25.8%)
Degree of stenosis: χ±SD (%) 82.5 ± 10.7
Length of stenotic lesions:  
χ±SD (mm) 11.5±3.9
Sodium mmol/L before 139.68±2.63
Sodium mmol/L 6 months after 139.42±1.51
Potassium mmol/L before 4.03±0.4
Potassium mmol/L 6 months after 4.08±0.29
Urea mmol/L before 7.23±2.18
Urea mmol/L 6 months after 7.52±1.7
Creatinine μmol/L before 109.58±12.37
Creatinine μmol/L 6 months after 109.45±15.12
Creatinine clearance corrected  
mL/min/1.73 m2 before 63.89±21.5
Creatinine clearance corrected  
mL/min/1.73 m2 6 months after 65.09±17.5
Systolic blood pressure before  
(mm Hg) 178.7±20.3
Systolic blood pressure 6 months after 
(mm Hg) 154.3±16.4
Diastolic blood pressure before  
(mm Hg) 99.5±13.1
Diastolic blood pressure 6 months 
after (mm Hg) 84.7±9.2
Antihypertensive drug number before 4.1±0.15
Antihypertensive drug number  
6 months after 2.9±0.07
AIx before 13.4±1.1
AIx 6 months after 1.1±0.2
PWVao before 13.7±2.6
PWVao 6 months after 12.6±2.6
PWVao = aortic pulse wave velocity; AIx = augmentation index; 
results are shown as mean ± SD or median (interquartile range)
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tensin-converting enzyme (ACE) inhibitors and an-
giotensin II receptor blockers  (ARBs) 30%, diuretics 
100%, Ca-channel blockers 82%, beta blockers 79%, 
urapidil/moxonidine 88%, and statins 69%. The distri-
bution of drugs at six-month follow up was as follows: 
ACE inhibitors and ARBs 100%, diuretics 94%, Ca-
channel blockers 36%, beta blockers 27%, urapidil/
moxonidine 42%, and statins 100%. There was no dif-
ference in the number and distribution of antihyper-
tensives between the two patient subgroups.
There were no differences in CKD grade 3, diabetes, 
prior myocardial infarction or stroke prevalence, or in 
the number of smokers between the two groups of pa-
tients with ostial and truncal renal artery stenosis, but 
peripheral artery disease was more frequent in the group 
with ostial renal artery stenosis (p=0.01) (Table 2).
Table 2. Demographic, clinical and hemodynamic characteristics of patients with renal artery stenosis (RAS)  
according to stenosis location
Ostial RAS Truncal RAS p
Age (years) 67.6±7.5 58.7±13.1 0.02
Body mass index (kg/m2) 26.6±2.7 28.8±3.1 NS
Sex male (n/%) 10 (43.4%) 5 (50%) NS
Hypercholesterolemia yes 21 (91.3%) 10 (100%) NS
Smokers yes 11 (47.8%)  2 (20%) NS
Ischemic heart disease 10 (43.4%) 2 (20%) NS
Cerebrovascular disease 4 (17.3%) 0 (0%) NS
Peripheral arterial disease 15 (65.2%) 2 (20%) 0.01
Diabetes 7 (30.4%) 2 (20%) NS
Degree of stenosis: χ±SD (%) 81.5±10.4 84.6±11.4 NS
Length of stenotic lesions: χ±SD (mm) 11.7±4.4 10.8±2.6 NS
Sodium mmol/L before 139.48±1.9 140.1±1.8 NS
Sodium mmol/L 6 months after 139.35±1.7 139.37±2.1 NS
Potassium mmol/l before 3.99±0.3 4.07±0.5 NS
Potassium mmol/L 6 months after 4.07±0.3 4.10±0.3 NS
Urea mmol/L before 7.71±2.3 6.37±2.1 NS
Urea mmol/L 6 months after 7.84±1.5 7.04±2.0 NS
Creatinine μmol/L before 109.70±23.7 111.60±30.2 NS
Creatinine μmol/L 6 months after 110.91±19.1 106.80±26.7 NS
Creatinine clearance corrected mL/min/1.73m2 before 56.0±18.2 60.7±20.0 NS
Creatinine clearance corrected mL/min/1.73 m2 6 months after 54.1±12.7 62.1±14.7 NS
Systolic blood pressure before (mm Hg) 178.0±19.8 181.1±21.6 NS
Systolic blood pressure 6 months after (mm Hg) 156.2±16.8 149.3±16.3 NS
Diastolic blood pressure before (mm Hg) 97.5±12.7 102.1±13.4 NS
Diastolic blood pressure 6 months after (mm Hg)  82.3±9.6  87.1±11.1 NS
Antihypertensive drug number before 4.0±0.18 3.9±0.21 NS
Antihypertensive drug number 6 months after 2.9±0.09 2.8±0.11 NS
AIx before 18.0±1.2 0.81±0.7 NS
AIx 6 months after 4.5±0.3 -9.3±1.1 NS
PWVao before 14.2±2.4 12.1±2.1 0.017
PWVao 6 months after 13.2±2.4 10.7±1.9 0.005
PWVao = aortic pulse wave velocity; AIx = augmentation index; results are shown as mean ± SD or median (interquartile range); 
NS = nonsignificant
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After the intervention and at six-month follow up, 
there was a significant decrease in both systolic and 
diastolic blood pressure (p<0.05 both). Both arterial 
stiffness markers, PWV and AIx, significantly de-
creased at six-month follow up (p<0.05 both). There 
were no differences in laboratory parameters and 
eGFR improvement at six-month follow up. When 
patients with renal artery stenosis were divided ac-
cording to sex, laterality of renal artery stenosis, sever-
ity of stenosis and eGFR level, no significant differ-
ences were found.
When compared to the initial values, PWV at six-
month follow up was significantly slower in patients 
with truncal renal artery stenosis and these patients 
were significantly younger (p<0.05 both). No differ-
ences in AIx values, systolic and diastolic blood pres-
sure, body mass index and laboratory values were 
found between patients with truncal and ostial renal 
artery stenosis before and after the intervention 
(p>0.05 all) (Table 2). On univariate analysis, survival 
was negatively correlated only with age in both patient 
subgroups (r=-0.457, p=0.007; r=-0.749, p<0.001). The 
impact of intervention on decrease of AIx and PWV 
values (p<0.05 both) was significant in both patient 
subgroups (p<0.05 both), especially in patients with 
truncal renal artery stenosis. In the linear regression 
model, except for age (β=-0.759, p<0.001), PWV be-
fore the intervention was the only predictor of shorter 
survival (β=-2.571, p=0.023).
After the first follow up at six months after the in-
tervention, when all measurements were repeated and 
the impact of stenting of renal arteries was analyzed, 
patients were followed-up for a total of 60 months. 
Twelve patients with ostial and one patient with trun-
cal renal artery stenosis (52% vs. 10%, p<0.001) died 
from cardiovascular events. The causes of cardiovascu-
lar deaths in the ostial renal artery stenosis group were 
stroke (n=3), myocardial infarction (n=4), heart failure 
(n=4) and aortic dissection (n=1), while one patient 
from the truncal renal artery stenosis group died from 
stroke. Out of 12 patients in the truncal renal artery 
stenosis group, there were eight women and four men 
(66% vs. 34%; p>0.05). When analyzing the whole 
group of patients, there was a significantly higher 
number of patients with lethal event who were suffer-
ing from peripheral artery disease compared to surviv-
ing patients (p=0.01), but there were no differences in 
the number of diabetics, smokers and patients with 
prior myocardial infarction and stroke (p>0.05 all).
Discussion
Renal artery stenosis is often an incidental finding 
in patients undergoing diagnostic evaluation for un-
controlled arterial hypertension or renal failure of un-
known origin7,18,19. It is diagnosed even more frequent-
ly in patients with advanced peripheral arterial dis-
ease20,21. Compared to general population, a higher 
prevalence of renal artery stenosis was found in pa-
tients with hypertension, ischemic nephropathy and 
cardiovascular disease, and it is reported that renal ar-
tery stenosis is associated with increased mortality as 
an independent risk factor18,19,22,23. Arterial stiffness is 
an important predictor of future cardiovascular events 
and all-cause mortality in many subgroups of patients 
but its role in patients with renal artery stenosis is still 
unknown. Higher arterial stiffness can additionally in-
crease the already high cardiovascular risk in these pa-
tients due to the fact that renal artery stenosis is asso-
ciated with target organ damage24, and is considered a 
risk factor for mortality. The severity of renal artery 
stenosis in our group of patients was >80%, which was 
similar to the reports from HERCULES study 
(81.3%)25, but higher than in CORAL study (72.5%)13. 
Technical and procedural effect of the interventions 
performed was complete, which was similar to many 
studies26,27. There were only two postprocedural com-
plications of pseudoaneurysm formation on femoral 
artery, which were successfully corrected by surgery. 
We found no cases of stent-restenosis at 6-month fol-
low up in our patients.
This study showed that endovascular intervention 
with antihypertensive drugs in the group of patients 
with renal artery stenosis led to a significant decrease 
of both arterial stiffness markers, PWV (-1.1±2.0 m/s; 
p<0.01) and AIx (-12.3±12.2%; p<0.001), at six-
month follow up. Stenting of renal arteries improved 
the blood pressure values and its control by decreasing 
the number of antihypertensive drugs but did not im-
prove renal function. It could be hypothesized that a 
decrease in AIx values was associated with the renin-
angiotensin-aldosterone system deactivation due to 
increased blood flow and decrease in sympathetic ac-
tivity and peripheral vascular resistance. Although 
PWV decreased significantly after the intervention, its 
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values were still pathologic, probably due to already ir-
reversible structural changes of the large artery walls. 
In this study, we found that patients with truncal renal 
artery stenosis had significantly lower PWV values 
than patients with ostial renal artery stenosis, although 
there were no differences between these two subgroups 
in AIx values, systolic and diastolic blood pressure val-
ues, and number of antihypertensives. The most plau-
sible explanation of this finding could be a higher inci-
dence of peripheral arterial disease as a marker of sub-
clinical organ damage and obviously more pronounced 
atherosclerosis, especially in large arteries, accompa-
nied by more advanced chronological age in patients 
with ostial renal artery stenosis.
Furthermore, a higher percentage of patients with 
renal artery stenosis and peripheral arterial disease 
died when compared to patients without peripheral 
vascular disease, which is in accordance with previous 
reports by McKenna et al.28 and Mui et al.29, where pe-
ripheral arterial disease per se and accompanied by re-
nal artery stenosis was associated with increased mor-
tality compared to other subgroups of patients. In the 
whole group and both subgroups of our patients, age 
and PWV before the intervention were strong and in-
dependent predictors of cardiovascular mortality, 
whereas AIx and both systolic and diastolic blood 
pressure values were not significant predictors at all. 
Ostial renal artery stenosis is not just a sign of ad-
vanced atherosclerosis of the aorta with its impact on 
higher PWV values, but is also the cause of higher per-
centage of fatal cardiovascular events. The overall death 
percentage of 39.3% in our group of patients with re-
nal artery stenosis was similar to the results reported 
by Wright et al.23, and was significantly lower than in 
other studies22,30. Nevertheless, our data suggest that 
renal artery stenosis has a poor prognosis, especially 
when accompanied by peripheral vascular disease. In 
contrast to some studies, we found no significant as-
sociation of renal failure or severity of renal artery ste-
nosis with increased mortality, but ostial renal artery 
stenosis as a marker of more pronounced atherosclero-
sis of large arteries was connected to a higher percent-
age of cardiovascular mortality at five-year follow up. 
The most important negative predictor of mortality, 
except for age, was PWV, confirming our presumption 
that atherosclerosis of large arteries, expressed as ostial 
renal artery stenosis, is dependent of PWV and more 
pronounced when compared to truncal renal artery 
stenosis.
This is the first study in the available literature that 
analyzed not only arterial stiffness but also cardiovas-
cular outcome in patients with different location of 
renal artery stenosis. Endovascular intervention on re-
nal arteries led to a significant decrease in both arterial 
stiffness markers, AIx and PWV, and to improved 
blood pressure control with a lower number of antihy-
pertensive drugs. In this longitudinal study, we con-
firmed our hypothesis and found ostial renal artery 
stenosis to be a marker of more pronounced athero-
sclerosis of large arteries.
Our work had several limitations, as follows: 1) we 
enrolled a relatively small number of patients and 
therefore we cannot extrapolate these results to all pa-
tients with renal artery stenosis; 2) secondly, before the 
intervention, patients were treated with different class-
es and combinations of antihypertensive drugs, where-
as afterwards all patients were treated with ACE in-
hibitors or ARBs and we cannot exclude the possible 
impact of these differences; 3) we did not enroll a con-
trol, healthy or hypertensive group of patients without 
renal artery stenosis; 4) we did not analyze renin and 
aldosterone levels in serum, which are elevated in pa-
tients with renal artery stenosis and therefore associ-
ated with progression of systemic atherosclerosis; and 
5) PWV was determined using Arteriograph, a device 
which is validated but with no reference cut-off values 
for patients with renal artery stenosis.
Conclusions
The impact of endovascular intervention on renal 
arteries leads to a significant decrease in both arterial 
stiffness markers, AIx and PWV, and to improved 
blood pressure control with a lower number of antihy-
pertensive drugs. The higher incidence of peripheral 
arterial disease and cardiovascular mortality found in 
patients with ostial renal artery stenosis is most likely 
due to more pronounced atherosclerosis of large arter-
ies and is accelerated with age.
References
 1. Jacobson HR. Ischemic renal disease: an overlooked clinical 
entity? Kidney Int. 1988;34:729-43.
 2. Valentine RJ, Myers SI, Miller GL, et al. Detection of unsus-
pected renal artery stenoses in patients with abdominal aortic 
aneurysms: refined indications for preoperative aortography. 
D. Perkov et al. Ostial renal artery stenosis and higher mortality
Acta Clin Croat, Vol. 58, No. 2, 2019 219
Ann Vasc Surg. 1993;7:220-4. https://doi.org/10.1007/BF0 
2000245
 3. Olin JW, Melia M, Young JR, et al. Prevalence of atherosclerosis 
renal artery stenosis in patients with atherosclerosis elsewhere. 
Am J Med. 1990;88:46-51.
 4. Crowley JJ, Santos RM, Peter RH, et al. Progression of renal 
artery stenosis in patients undergoing cardiac catheterization. 
Am Heart J. 1998;136:913-8.
 5. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of 
atherosclerotic disease progression in the renal artery. Circula-
tion. 1998;98:2866-72.
 6. Olin JW. Atherosclerotic renal artery disease. Cardiol Clin. 
2002;20:547-62.
 7. Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular 
disease predicts mortality in patients undergoing coronary an-
giography. Kidney Int. 2001;60:1490-7. https://doi.org/ 
10.1046/j.1523-1755.2001.00953.x
 8. Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate 
endpoint for cardiovascular disease? J Nephrol. 2007;20(12): 
45-50.
 9. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of 
cardiovascular events and all-cause mortality with arterial stiff-
ness: a systematic review and meta-analysis. J Am Coll Cardiol. 
2010;55:1318-27. https://doi.org/10.1016/j.jacc.2009.10.061
10. Vlachopoulos C, Aznaouridis K, O’Rourke MF, et al. Prediction 
of cardiovascular events and all-cause mortality with central 
haemodynamics: a systematic review and meta-analysis. Eur 
Heart J. 2010;31:1865-71. https://doi.org/10.1093/eurheartj/
ehq024
11. Fodor L, Premužić V, Ivković V, et al. Arterial stiffness in athero-
sclerotic renovascular hypertension. J Hypertens. 2014;32(11): 
2238-45. https://doi.org/10.1097/HJH.0000000000000324
12. Mui KW, Sleeswijk M, van den Hout H, et al. Incidental renal 
artery stenosis is an independent predictor of mortality in pa-
tients with peripheral vascular disease. J Am Soc Nephrol. 
2006;17:2069-74. https://doi.org/10.1681/ASN.2005080827
13. Cooper C, Murphy T, Cutlip D, et al. CORAL Investigators. 
Stenting and medical therapy for atherosclerotic renal-artery 
stenosis. N Engl J Med. 2014;370:13-22. https://doi.
org/10.1056/NEJMoa1310753
14. Textor S, Misra S, Oderich G. Percutaneous revascularization 
for ischemic nephropathy: the past, present, and future: Kidney 
Int. 2013;83:28-40. https://doi.org/10.1038/ki.2012.363
15. Rocha-Singh K, Eisenhauer A, Textor S, et al. American Heart 
Association Writing Group 8. Atherosclerotic Peripheral Vas-
cular Disease Symposium II: Intervention for renal artery dis-
ease. Circulation. 2008;118:2873-8. https://doi.org/10.1161/
CIRCULATIONAHA.108.191178
16. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of 
balloon angioplasty on hypertension in atherosclerotic renal-
artery stenosis. Dutch Renal Artery Stenosis Intervention Co-
operative Study Group. N Engl J Med. 2000;342:1007-14. 
https://doi.org/10.1056/NEJM200004063421403
17. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimen-
tal hypertension: production of persistent elevation of systolic 
blood pressure by means of renal ischemia. J Exp Med. 1934; 
59:347-79. https://doi.org/10.1084/jem.59.3.347
18. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular 
disease in United States patients aged 67 years or older: risk fac-
tors, revascularization, and prognosis. Kidney Int. 2005;68: 
293-301. https://doi.org/10.1111/j.1523-1755.2005.00406.x
19. Wright JR, Shurrab AE, Cooper A, et al. Left ventricular mor-
phology and function in patients with atherosclerotic renovas-
cular disease. J Am Soc Nephrol. 2005;16:2746-53. https://doi.
org/10.1681/ASN.2005010043
20. Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. 
Incidental renal artery stenosis in peripheral vascular disease: a 
case for treatment? Kidney Int. 2001;59:1480-3. https://doi.
org/10.1046/j.1523-1755.2001.0590041480.x
21. Pillay WR, Kan YM, Crinnion JN, et al. Prospective multicentre 
study of the natural history of atherosclerotic renal artery steno-
sis in patients with peripheral vascular disease. Br J Surg. 2002; 
89:737-40. https://doi.org/10.1046/j.1365-2168.2002.02144.x
22. Isles C, Main J, O’Connell J, et al. Survival associated with re-
novascular disease in Glasgow and Newcastle: a collaborative 
study. Scott Med J. 1990;35:70-3. https://doi.org/10.1177/ 
003693309003500303
23. Wright JR, Shurrab AE, Cheung C, et al. A prospective study 
of the determinants of renal functional outcome and mortality 
in atherosclerotic renovascular disease. Am J Kidney Dis. 2002; 
39:1153-61. https://doi.org/10.1053/ajkd.2002.33384
24. Novick AC, Pohl MA, Schrieber M, et al. Revascularization for 
preservation of renal function in patients with atherosclerotic 
renovascular disease. J Urol. 1983;129:907-12.
25. Jaff MR, Bates M, Sullivan T, et al. HERCULES Investigators. 
Significant reduction in systolic blood pressure following renal 
artery stenting in patients with uncontrolled hypertension: re-
sults from the HERCULES trial. Catheter Cardiovasc Interv. 
2012;80(3):343-50. https://doi.org/10.1002/ccd.24449
26. Sekkarie M. Treatment of renal artery stenosis by invasive pro-
cedures. Am J Kidney Dis. 1999;33(3):613-4.
27. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angio-
plasty and stent placement: predictors of a favorable outcome. 
Am Heart J. 2000;139(1):64-71.
28. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm 
arterial pressure as an independent predictor of mortality. Ath-
erosclerosis. 1991;87:119-28.
29. Mui KW, Zeebregts CJ, van den Hout H, et al. Impact of inci-
dental renal artery stenosis on long-term mortality in patients 
with peripheral arterial disease undergoing vascular procedure. 
J Vasc Surg. 2011;54(3):785-90. https://doi.org/10.1016/j.
jvs.2011.03.251
30. Wollenweber J, Sheps SG, Davis GD. Clinical course of 
 atherosclerotic renovascular disease. Am J Cardiol. 1968;21: 
60-71.
D. Perkov et al. Ostial renal artery stenosis and higher mortality
220 Acta Clin Croat, Vol. 58, No. 2, 2019
Sažetak
USPOREDBA OSTIJALNOG I TRUNKALNOG SUŽENJA BUBREŽNE ARTERIJE:  
PREDIKTOR POŠIRENOSTI ATEROSKLEROZE VELIKIH ARTERIJA I VEĆE SMRTNOSTI
D. Perkov, V. Premužić, R. Smiljanić, Lj. Fodor, S. Dobrota i B. Jelaković
Cilj ovog istraživanja bio je utvrditi krutost arterija i učinak stentiranja u bolesnika sa suženjem bubrežne arterije. Hipo-
teza je bila da ostijalno suženje bubrežne arterije nije samo pokazatelj izraženije ateroskleroze velikih arterija, nego je i pre-
diktor veće kardiovaskularne smrtnosti. U istraživanje smo uključili 33 bolesnika sa suženjem bubrežne arterije koji su bili 
refraktorni na farmakološko liječenje i podijelili ih prema položaju suženja bubrežne arterije, ostijalnom i trunkalnom (23 
naspram 10 bolesnika). Analizirali smo preživljenje bolesnika nakon petogodišnjeg praćenja. Neposredno nakon interven cije 
i šest mjeseci nakon intervencije došlo je do značajnog smanjenja vrijednosti krvnog tlaka, kao i brzine pulsnog vala (PWV) 
i indeksa augmentacije. Brzina pulsnog vala (pulse wave velocity, PWV) je bila značajno niža u bolesnika s trunkalnim suže-
njem arterije i ti su bolesnici bili značajno mlađi. Dvanaest bolesnika s ostijalnom i jedan bolesnik s trunkalnim suženjem 
bubrežne arterije (52% naspram 10%, p<0,001) umrlo je od kardiovaskularnih događaja. Naša studija je prva koja potvrđuje 
prediktivnu ulogu PWV i arterijske krutosti u bolesnika sa suženjem bubrežne arterije, osobito ostijalnim, te naglašava 
 njezinu sposobnost otkrivanja buduće veće incidencije kardiovaskularnih događaja.
Ključne riječi: Bubrežna arterija, opstrukcija; Ateroskleroza; Pulsni val, analiza; Vaskularna krutost; Mortalitet; Preživ­
ljavanje
